Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
12.12
+0.44 (3.77%)
Apr 28, 2025, 4:08 PM HKT

HKG:2315 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
33.54-382.95-601.95-545.58-428.09
Depreciation & Amortization
169.18182.45174.1128.143.37
Loss (Gain) From Sale of Assets
--1.830.08-0.391.2
Loss (Gain) From Sale of Investments
--0.15-44.7-2.13-6.19
Loss (Gain) on Equity Investments
-10.0314.770.4-0.09
Stock-Based Compensation
-30.9815.3127.75132.45
Provision & Write-off of Bad Debts
-4.281.423.121.51
Other Operating Activities
8.5389.842.0433.1359.76
Change in Accounts Receivable
--39.02-4.59-35.86-32.38
Change in Inventory
-3.79-6.4-29.96-5.29
Change in Accounts Payable
-11.947.3519.0416.78
Change in Unearned Revenue
-9.98-8.0716.758.49
Change in Income Taxes
---0.8--
Change in Other Net Operating Assets
-4.168.1719.86-16.84
Operating Cash Flow
211.25-76.65-303.27-365.78-225.31
Capital Expenditures
-68.8-126.62-240.27-198.67-296.42
Sale of Property, Plant & Equipment
-26.341.644.760.05
Divestitures
---6.86--
Investment in Securities
--91.76109.78108.2
Other Investing Activities
-68.32----
Investing Cash Flow
-137.12-100.28-153.74-84.13-188.18
Long-Term Debt Issued
-319.91209.6--
Long-Term Debt Repaid
--312.37-68.77-57.13-75.91
Net Debt Issued (Repaid)
-7.54140.83-57.13-75.91
Issuance of Common Stock
--521.06311.04948.36
Repurchase of Common Stock
--8.2-18.99--
Other Financing Activities
-92.03-37.16-55.69-34.47-4.01
Financing Cash Flow
-92.03-37.82587.2219.44868.44
Foreign Exchange Rate Adjustments
2.753.4714.24-0.38-4.04
Net Cash Flow
-15.15-211.28144.44-230.85450.91
Free Cash Flow
142.45-203.26-543.54-564.45-521.73
Free Cash Flow Margin
14.53%-28.35%-101.81%-159.20%-205.78%
Free Cash Flow Per Share
0.36-0.51-1.43-1.56-4.04
Cash Interest Paid
-24.08177.664.01
Cash Income Tax Paid
-0.64---
Levered Free Cash Flow
-29.6-231.5-423.55-397.16-
Unlevered Free Cash Flow
27.7-169.1-388.46-372.52-
Change in Net Working Capital
189.1773.71-40.275.29-
Updated Sep 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.